Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Oct 5 - Oct 10
The largest Phase 2b trial (502 participants, 24 weeks) did not show statistically significant weight loss versus placebo
This guide provides everything you need for precise AOD-9604 administration
What Is 5 Amino 1MQ Peptide
consistent ~12-15% weight loss at 68 weeks Compound Tirzepatide (Zepbound) Class GIP/GLP-1 dual agonist FDA Status FDA-approved for chronic weight management Evidence Strength Phase 3 RCTs
Petechial spots do not typically cause pain or itching
Multiple compounds targeting the same pathways may cause excessive stimulation or unpredictable interactions
US$ 23.08
US$ 20.62
US$ 23.14
US$ 27.10
US$ 26.20
US$ 21.19
US$ 20.91
US$ 26.27
US$ 22.13
US$ 25.93
